undamentalytics Newsletter

Sanuwave Health, Inc. income statement

In fiscal 2025, Sanuwave Health, Inc. reported revenue of $44.1m, up 35.0% on the year before, operating income of $4.9m (a 11.2% margin) and net income of $11.8m, or $0.41 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Sanuwave Health, Inc.: income statement, annual
Fiscal year2010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue11111111224131720334444
Cost of revenue0000001011154681010
Gross profit0111111010381214253434
Research and development43223211111111112
Selling and marketing————————125975679
General and administrative76543333761412139131920
Operating income−12−9−6−6−6−4−3−4−7−9−25−14−9−1452
Interest expense10000011422713—13——
Income before tax−15−10−6−12−6—————————−3312—
Income tax−0000000000000000—
Net income−15−10−6−11−6−5−6−6−12−10−31−27−10−26−331215
Diluted EPS−$0.29−$0.13−$0.07−$0.10−$0.03−$0.02−$0.01−$0.01−$0.02−$0.01−$0.02−$0.01−$0.01−$3.05−$3.71$0.41$1.70
Diluted shares (average)52m78m84m113m193m252m430m555m598m814m1,513m2,073m2,198m8m9m9m9m
EBITDA−11−9−6−6−6−4−3−4−7−9−25−13−80563

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: MYO vs SNWVSNWV vs TLSIKRMD vs SNWVCLPT vs SNWV

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Sanuwave Health, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Sanuwave Health, Inc.